Lupin gets tentative USFDA nod for Dolutegravir, Emtricitabine and Tenofovir Alafenamide tablets
The tentative approval by the United States Food and Drug Administration (USFDA) has been granted under the President's emergency plan for AIDS relief (PEPFAR), Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 31, 2023 Category: Pharmaceuticals Source Type: news
HIV Prevention: New Injection Could Boost the Fight, But Some Hurdles Remain
This article is republished from The Conversation under a Creative Commons license. Read the original article. (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - November 30, 2022 Category: International Medicine & Public Health Authors: External Source Tags: Global Headlines Health Poverty & SDGs #HIV/Aids Source Type: news
A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation A Switch to B/F/TAF Keeps HIV Suppressed, Even With Mutation
In people with suppressed HIV, including those with the M184V/I viral mutation, switching to combined bictegravir, emtricitabine, and tenofovir alafenamide has high efficacy, researchers report.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2022 Category: Consumer Health News Tags: HIV/AIDS News Source Type: news
Government can't mandate coverage for drugs that prevent HIV infections, Texas federal judge rules
The lawsuit challenged a provision of the Affordable Care Act that required free coverage of the HIV drugs Truvada and Descovy, commonly known as PrEP, that thousands of Americans take. #truvada #descovy #affordablecareact (Source: Reuters: Health)
Source: Reuters: Health - September 7, 2022 Category: Consumer Health News Source Type: news
Truvada (Emtricitabine Tenofovir DF) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 16, 2022 Category: Drugs & Pharmacology Source Type: news
FDA Approves First Injection Regimen for HIV Prevention
Until now, two types of daily pills (Truvada and Descovy) were the only options for what's called pre-exposure prophylaxis (PrEP). (Source: WebMD Health)
Source: WebMD Health - December 21, 2021 Category: Consumer Health News Source Type: news
Cabotegravir Bests TDF-FTC for HIV Prevention in Those at Risk
THURSDAY, Aug. 12, 2021 -- For men who have sex with men (MSM) and transgender women, long-acting injectable cabotegravir (CAB-LA, an integrase strand-transfer inhibitor [INSTI]) is superior to tenofovir disoproxil fumarate-emtricitabine (TDF-FTC)... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2021 Category: Pharmaceuticals Source Type: news
PrEP HIV Prevention Pills to Be Free for Insured Americans
WEDNESDAY, July 21, 2021 -- Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says. That includes the two approved pre-exposure prophylaxis (PrEP) drugs Truvada and Descovy, all clinic visits,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2021 Category: Pharmaceuticals Source Type: news
PrEP HIV Prevention Pills to Be Free for Insured Americans
Nearly all health insurers must cover the entire cost of HIV prevention treatments. The two approved pre-exposure prophylaxis (PrEP) drugs are Truvada and Descovy. (Source: WebMD Health)
Source: WebMD Health - July 21, 2021 Category: Consumer Health News Source Type: news
PrEP HIV Prevention Pills to Be Free for Insured Americans
WEDNESDAY, July 21, 2021 -- Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says.
That includes the two approved pre-exposure prophylaxis (PrEP) drugs Truvada and Descovy, all clinic visits... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 21, 2021 Category: General Medicine Source Type: news
Lupin gets USFDA nod to market generic HIV drug
The company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Disoproxil Fumarate tablets, 200 mg/300 mg, Lupin said in a regulatory filing. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - June 7, 2021 Category: Pharmaceuticals Source Type: news
Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate)
Title: Complera (emtricitabine, rilpivirine, tenofovir disoproxil fumarate)Category: MedicationsCreated: 5/27/2021 12:00:00 AMLast Editorial Review: 5/27/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 27, 2021 Category: Drugs & Pharmacology Source Type: news
Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)
Title: Symtuza (darunavir, cobicistat, emtricitabine, and tenofovir alafenamide)Category: MedicationsCreated: 4/30/2021 12:00:00 AMLast Editorial Review: 4/30/2021 12:00:00 AM (Source: MedicineNet HIV General)
Source: MedicineNet HIV General - April 30, 2021 Category: Infectious Diseases Source Type: news
Strides Pharma Science arm gets USFDA nod for HIV treatment drug
Drug firm Strides Pharma Science on Friday said its step-down wholly-owned subsidiary, Strides Pharma Global, has received approval from the US health regulator for Emtricitabine and Tenofovir Disoproxil Fumarate tablets, used to treat HIV. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2021 Category: Pharmaceuticals Source Type: news
Shot to Prevent H.I.V. Works Better Than Daily Pill in Women
Researchers ended a clinical trial of the drug early because the results were so convincing. The more effective drug would be given in six injections a year instead of as 365 daily pills. (Source: NYT Health)
Source: NYT Health - November 9, 2020 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: your-feed-science Clinical Trials Acquired Immune Deficiency Syndrome Women and Girls Truvada (Drug) Drugs (Pharmaceuticals) Viiv Healthcare Ltd Gilead Sciences Inc Source Type: news
